Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04)
University of Michigan Rogel Cancer Center
University of Michigan Rogel Cancer Center
Elevation Oncology
EMD Serono
National Cancer Institute (NCI)
New Mexico Cancer Research Alliance
University of Miami
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Stanford University
Massachusetts General Hospital